Portfolio company
HighLife
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
3 investors
Sectors
Digital Health
About
This company develops transcatheter mitral valve replacement systems for patients suffering from mitral regurgitation who are unsuitable for conventional heart surgery.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.